Published in Trends Neurosci on June 01, 1999
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A (2000) 4.01
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A (2000) 3.82
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A (2002) 3.56
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum Mol Genet (2011) 2.34
An actin-binding protein of the Sla2/Huntingtin interacting protein 1 family is a novel component of clathrin-coated pits and vesicles. J Cell Biol (1999) 2.10
Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol (2004) 1.90
Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol (2001) 1.42
Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD. PLoS One (2015) 1.40
Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev (2009) 1.37
The endoplasmic reticulum stress response in aging and age-related diseases. Front Physiol (2012) 1.35
Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity. J Neurosci (2008) 1.28
Cellular stress/the unfolded protein response: relevance to sleep and sleep disorders. Sleep Med Rev (2009) 1.27
Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity. Proc Natl Acad Sci U S A (2002) 1.24
Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med (2008) 1.22
Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res (2011) 1.17
Huntington's disease. Mol Pathol (2001) 1.16
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta (2011) 1.16
Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors. J Cell Biol (2005) 1.07
Drosophila couch potato mutants exhibit complex neurological abnormalities including epilepsy phenotypes. Genetics (2005) 1.01
Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc Natl Acad Sci U S A (2005) 1.00
Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission. Drug Discov Today (2014) 0.97
Apoptosis gene profiling reveals spatio-temporal regulated expression of the p53/Mdm2 pathway during lens development. Exp Eye Res (2009) 0.93
The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice. Neurobiol Dis (2012) 0.83
Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease. Hum Mol Genet (2015) 0.82
Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy. Int J Biomed Sci (2011) 0.82
Integration of apoptosis signal-regulating kinase 1-mediated stress signaling with the Akt/protein kinase B-IκB kinase cascade. Mol Cell Biol (2013) 0.82
Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease. Hum Mol Genet (2016) 0.77
Systematic analysis of γ-aminobutyric acid (GABA) metabolism and function in the social amoeba Dictyostelium discoideum. J Biol Chem (2013) 0.76
Conference report--highlights of the 4th EMBO/EMBL joint conference on genetics, determinism and human freedom, November 14-15, 2003; Heidelberg, Germany. MedGenMed (2004) 0.75
The education of a brain transplant. Proc Natl Acad Sci U S A (1999) 0.75
Cytosolic selection systems to study protein stability. J Bacteriol (2014) 0.75
Neuroscience from different angles. Student symposium: from genes to thoughts. EMBO Rep (2001) 0.75
Beneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease. Brain Behav (2014) 0.75
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies. Curr Neuropharmacol (2006) 0.75
The sequence of the human genome. Science (2001) 101.55
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
A Critical Study of the Methods of Estimating Cholesterol and Allied Substances. Biochem J (1921) 4.58
Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55
A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41
Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J (2001) 4.40
TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell (1995) 4.34
Lymphocyte trafficking and regional immunity. Adv Immunol (1999) 4.21
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05
Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol Cell Biol (1992) 3.57
Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37
Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (1985) 3.32
Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (1996) 3.18
The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet (1995) 3.05
Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science (1977) 2.88
Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry (2001) 2.83
Final results from a meta-analysis of remedial interventions with drink/drive offenders. Addiction (1995) 2.66
Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer (1998) 2.36
Molecular evolution of the psi eta-globin gene locus: gibbon phylogeny and the hominoid slowdown. Mol Biol Evol (1991) 2.33
Globins: a case study in molecular phylogeny. Cold Spring Harb Symp Quant Biol (1987) 2.23
Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res (1998) 2.17
Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry (1998) 2.16
Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15
Possible discrimination in recruitment of psychiatry residents? Am J Psychiatry (1997) 2.14
The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12
Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord (1998) 2.10
Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci (1997) 2.09
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem (1992) 2.01
The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. Development (1991) 2.01
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther (1989) 1.99
Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol (1987) 1.97
Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97
Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J (1999) 1.90
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science (1998) 1.87
P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther (2000) 1.85
Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet (1998) 1.83
Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol (2001) 1.77
Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet (1997) 1.76
Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74
Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry (2000) 1.74
Peer discussion on training physicians to be competent communicators: support for a multiple discourse approach. South Med J (1997) 1.73
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 1.72
A phosphatocopid crustacean with appendages from the Lower Cambrian. Science (2001) 1.70
Adherence by African American men to prostate cancer education and early detection. Cancer (1999) 1.69
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet (1993) 1.67
Liver cells. Methods Enzymol (1979) 1.67
The carbon balance of Africa: synthesis of recent research studies. Philos Trans A Math Phys Eng Sci (2011) 1.65
Sensitivity of Shah, Vanclay and Cooper's modified Barthel Index. Clin Rehabil (1999) 1.62
Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study. Am J Clin Pathol (1991) 1.61
Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2000) 1.61
Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther (2000) 1.60
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med (2012) 1.60
Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry (2001) 1.59
Primate evolution at the DNA level and a classification of hominoids. J Mol Evol (1990) 1.58
HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse (1998) 1.58
Genetics and molecular biology of Huntington's disease. Trends Neurosci (1995) 1.57
UK Back pain Exercise And Manipulation (UK BEAM) trial--national randomised trial of physical treatments for back pain in primary care: objectives, design and interventions [ISRCTN32683578]. BMC Health Serv Res (2003) 1.57
One minute wisdom. All you need to know about CS gas. Nurs Stand (1994) 1.55
Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation (2000) 1.55
Autonomic orienting responses in 15-year-old male subjects and criminal behavior at age 24. Am J Psychiatry (1990) 1.54
Sale of sex for drugs and drugs for sex: an economic context of sexual risk behavior for STDs. Sex Transm Dis (1999) 1.53
Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci (2001) 1.52
CT appearances of talc pleurodesis. Clin Radiol (2007) 1.52
Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc Natl Acad Sci U S A (1989) 1.50
A molecular view of primate phylogeny and important systematic and evolutionary questions. Mol Biol Evol (1989) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49
Duplication of the gamma-globin gene mediated by L1 long interspersed repetitive elements in an early ancestor of simian primates. Proc Natl Acad Sci U S A (1991) 1.48
Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr (1984) 1.48
The hypronosticon test in breast cancer. Clin Oncol (1975) 1.47
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A (1993) 1.47
Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J Cell Biol (1995) 1.46
Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis (2001) 1.44
Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists. Trends Pharmacol Sci (1997) 1.44
Agonist derived molecular probes for A2 adenosine receptors. J Mol Recognit (1989) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
An investigation of psychological distress in patients who have been treated for head and neck cancer. Br J Oral Maxillofac Surg (2001) 1.42
Phosphorylation-dephosphorylation of pyruvate dehydrogenase complex from pea leaf mitochondria. Arch Biochem Biophys (1981) 1.42
Assessing dopamine concentrations: an evidence-based approach. Am J Crit Care (2000) 1.41
Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci (1999) 1.40
Is GIFT (gamete intrafallopian transfer) the best treatment for unexplained infertility? Br J Obstet Gynaecol (1991) 1.40
Maternal fatigue: implications of second stage labor nursing care. J Obstet Gynecol Neonatal Nurs (1999) 1.40
Nursing orientation: a continuous quality improvement story. Clin Nurse Spec (1996) 1.40
Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med (1980) 1.40
The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci U S A (1997) 1.39